tacrolimus (standard GVHD prophylaxis)

DRUG2 trials

Sponsors

University of Michigan Rogel Cancer Center, Pavan Reddy, MD

Conditions

Graft Versus Host DiseaseGraft vs Host DiseaseHematologic Malignancies

Phase 1

Vorinostat to Prevent Graft Versus Host Disease Following Reduced Intensity, Related Donor Stem Cell Transplant

CompletedNCT00810602

Pavan Reddy, MDGraft vs Host Disease, Hematologic Malignancies

Start: 2009-01-31End: 2013-07-31Updated: 2014-04-11

Phase 2

Addition of Etanercept and Extracorporeal Photopheresis (ECP) to Standard Graft-Versus-Host Disease (GVHD) Prophylaxis in Stem Cell Transplant

CompletedNCT00639717

University of Michigan Rogel Cancer CenterGraft Versus Host Disease

Start: 2009-03-31End: 2016-04-30Updated: 2017-08-01

Related Papers

Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial.

2013-11-30100 citations